|Bid||0.00 x 800|
|Ask||0.00 x 1800|
|Day's Range||6.97 - 7.20|
|52 Week Range||6.72 - 21.88|
|Beta (5Y Monthly)||0.61|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 04, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||16.50|
Subscribe to Yahoo Finance Plus to view Fair Value for ANGO
LATHAM, N.Y., September 12, 2023--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that it will report financial results for the first quarter of fiscal year 2024 before the market open on Wednesday, October 4, 2023. The Company’s management will host a conference call at 8:00 a.m. ET the s
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
AngioDynamics (ANGO) closed at $7.02 in the latest trading session, marking a -0.71% move from the prior day.